BioLife Solutions, Inc. (BLFS)
BLFS Stock Price Chart
Explore BioLife Solutions, Inc. interactive price chart. Choose custom timeframes to analyze BLFS price movements and trends.
BLFS Company Profile
Discover essential business fundamentals and corporate details for BioLife Solutions, Inc. (BLFS) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Medical - Instruments & Supplies
IPO Date
22 Nov 1989
Employees
159.00
Website
https://www.biolifesolutions.comCEO
Roderick de Greef
Description
BioLife Solutions, Inc. (BLFS) operates as a global provider of specialized bioproduction tools and services, primarily catering to the cell and gene therapy industry. Its market reach extends across the United States, Canada, Europe, the Middle East, Africa, and other international regions. The company's offerings are essential for various stages of biologic-based therapy development, spanning from foundational and applied research to large-scale commercial manufacturing. Key products include proprietary biopreservation media, such as HypoThermosol FRS and CryoStor, which are engineered to minimize delayed cell damage and death typically associated with preservation. Complementing these are the ThawSTAR products, an automated line of devices for thawing vials and cryobags, designed to precisely manage the heat and timing for optimal biologic material thawing. BLFS also provides innovative cloud-connected evo shipping containers for the passive storage and secure transport of temperature-sensitive biologics and pharmaceuticals. Additionally, its comprehensive range encompasses liquid nitrogen laboratory freezers, various cryogenic equipment and accessories, and specialized storage services for biological and pharmaceutical products. Products are distributed both directly to customers and through a network of third-party distributors. Established in 1987, BioLife Solutions, Inc. maintains its headquarters in Bothell, Washington.
BLFS Financial Timeline
Browse a chronological timeline of BioLife Solutions, Inc. corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 6 Aug 2026
EPS estimate is -$0.02, while revenue estimate is $27.57m.
Earnings released on 7 May 2026
EPS came in at $0.04 surpassing the estimated $0.01 by +300.00%, while revenue for the quarter reached $27.50m , beating expectations by +7.15%.
Earnings released on 26 Feb 2026
EPS came in at $0.04 surpassing the estimated -$0.02 by +300.00%, while revenue for the quarter reached $24.76m , beating expectations by +2.85%.
Earnings released on 6 Nov 2025
EPS came in at $0.04 surpassing the estimated $0.00 by +1.90k%, while revenue for the quarter reached $28.07m , beating expectations by +9.25%.
Earnings released on 7 Aug 2025
EPS came in at -$0.33 falling short of the estimated -$0.03 by -888.51%, while revenue for the quarter reached $25.42m , missing expectations by -1.05%.
Earnings released on 8 May 2025
EPS came in at $0.04 surpassing the estimated -$0.05 by +182.36%, while revenue for the quarter reached $23.94m , beating expectations by +7.74%.
Earnings released on 3 Mar 2025
EPS came in at -$0.01 surpassing the estimated -$0.06 by +83.33%, while revenue for the quarter reached -$3.42m , missing expectations by -115.69%.
Earnings released on 12 Nov 2024
EPS came in at -$0.02 surpassing the estimated -$0.08 by +74.47%, while revenue for the quarter reached $30.57m , beating expectations by +41.86%.
Earnings released on 8 Aug 2024
EPS came in at -$0.06 surpassing the estimated -$0.14 by +56.63%, while revenue for the quarter reached $19.72m , missing expectations by -17.68%.
Earnings released on 9 May 2024
EPS came in at -$0.23 surpassing the estimated -$0.28 by +17.86%, while revenue for the quarter reached $18.43m , missing expectations by -29.13%.
Earnings released on 29 Feb 2024
EPS came in at -$0.30 surpassing the estimated -$0.34 by +11.76%, while revenue for the quarter reached $17.39m , missing expectations by -47.93%.
Earnings released on 9 Nov 2023
EPS came in at -$0.67 falling short of the estimated -$0.38 by -78.67%, while revenue for the quarter reached $23.57m , missing expectations by -30.30%.
Earnings released on 8 Aug 2023
EPS came in at -$0.23 falling short of the estimated -$0.20 by -15.00%, while revenue for the quarter reached $39.51m , missing expectations by -9.92%.
Earnings released on 10 May 2023
EPS came in at -$0.32 falling short of the estimated -$0.21 by -52.38%, while revenue for the quarter reached $37.70m , missing expectations by -12.20%.
Earnings released on 16 Mar 2023
EPS came in at -$1.15 falling short of the estimated -$0.17 by -576.47%, while revenue for the quarter reached $44.26m , beating expectations by +2.26%.
Earnings released on 9 Nov 2022
EPS came in at -$0.23 falling short of the estimated -$0.17 by -35.29%, while revenue for the quarter reached $40.75m , missing expectations by -3.13%.
Earnings released on 9 Aug 2022
EPS came in at -$1.71 falling short of the estimated -$0.21 by -718.61%, while revenue for the quarter reached $40.53m , beating expectations by +3.48%.
Earnings released on 9 May 2022
EPS came in at -$0.17 surpassing the estimated -$0.25 by +32.00%, while revenue for the quarter reached $36.22m , missing expectations by -5.20%.
Earnings released on 28 Feb 2022
EPS came in at -$0.37 falling short of the estimated -$0.17 by -117.65%, while revenue for the quarter reached $37.30m , beating expectations by +4.16%.
Earnings released on 11 Nov 2021
EPS came in at $0.00 surpassing the estimated -$0.09 by +102.02%, while revenue for the quarter reached $33.80m , missing expectations by -90.34%.
Earnings released on 12 Aug 2021
EPS came in at $0.19 surpassing the estimated -$0.05 by +480.00%, while revenue for the quarter reached $31.20m , meeting expectations.
BLFS Stock Performance
Access detailed BLFS performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.
